Mechanistic registry to examine whether the coronavirus disease 2019 (COVID-19) accelerates atherosclerotic plaque progression
COVID CT Registry (COVID Cohort)
Sponsor: National Cancer Institute
Enrolling: Male and Female Patients
Clinic Visits: 2
IRB Number: AAAT9812
Contact: Michelle Castillo: 732-277-7644 / mc5067@cumc.columbia.edu
Additional Study Information: We are seeking patients that have had a pre-COVID heart CT scan (Coronary Computed Tomography Angiography) that was performed at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital before March of 2020. For this study, half of patients will be required to have had COVID-19 symptoms (e.g., fever, cough, shortness of breath) and would have tested positive for COVID-19 (by an FDA-approved test). The other half will not have had a prior diagnosis of COVID-19. If you enroll in the study, you will be given a CT, asked to provide a blood sample as well as answer the study questionnaires, and get an ECG done. The total duration of the tests is 3 hours. It can be done in 1 or 2 study visits, whichever works best for your schedule. You will be compensated $100 after all tests are completed.
Investigator
Andrew Einstein, MD
Do You Qualify?
Have you had a heart CT (coronary computed tomography angiography) before March 2020 at Columbia? Yes No
Have you have COVID-19? Yes No
Did you visit an urgent care, emergency department or a COVID clinic for care? Yes No
Were you admitted to the hospital with COVID? Yes No
Did you get a lipid (cholesterol) test done? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder


CAPTCHA
Image CAPTCHA
Enter the characters shown in the image.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.


For more information, please contact:
Michelle Castillo
mc5067@cumc.columbia.edu
732-277-7644